CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-14 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −6,257 | $69.24 | $433K | 64,333 |
| 2026-04-13 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −400 | $69.00 | $28K | 70,590 |
| 2026-02-25 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −353 | $69.06 | $24K | 70,990 |
| 2026-02-18 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −3,397 | $65.01 | $221K | 75,027 |
| 2026-02-18 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −3,684 | $65.89 | $243K | 71,343 |
| 2026-02-17 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −4,075 | $62.86 | $256K | 78,424 |
| 2026-02-10 | Franchi Jean M. Chief Financial Officer | Grant or award | +19,000 | 82,499 | ||
| 2026-02-10 | Franchi Jean M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,500 | 25,500 | ||
| 2025-07-17 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −2,031 | $59.00 | $120K | 63,499 |
| 2025-07-10 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −2,000 | $57.50 | $115K | 65,530 |
| 2025-06-16 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −2,000 | $52.26 | $105K | 67,530 |
| 2025-02-18 | Franchi Jean M. Chief Financial Officer | Sale | −3,136 | $54.58 | $171K | 69,530 |
| 2025-02-10 | Franchi Jean M. Chief Financial Officer | Grant or award | +36,000 | 72,666 | ||
| 2025-02-10 | Franchi Jean M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-02-07 | Franchi Jean M. Chief Financial Officer | Grant or award | +36,666 | 36,666 | ||
| 2024-02-07 | Franchi Jean M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 |
Page 1 of 1 · 16 trades